- Previous Close
56.71 - Open
56.70 - Bid 55.77 x 200
- Ask 55.85 x 100
- Day's Range
55.07 - 56.97 - 52 Week Range
53.22 - 87.77 - Volume
2,462,129 - Avg. Volume
1,184,387 - Market Cap (intraday)
5.266B - Beta (5Y Monthly) 1.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.08 - Earnings Date Oct 31, 2024 - Nov 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
88.75
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
www.acadiahealthcare.com23,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ACHC
View More
Performance Overview: ACHC
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACHC
View MoreValuation Measures
Market Cap
5.27B
Enterprise Value
7.16B
Trailing P/E
--
Forward P/E
14.47
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.69
Price/Book (mrq)
1.78
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
30.27
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.17%
Return on Assets (ttm)
6.13%
Return on Equity (ttm)
0.13%
Revenue (ttm)
3.06B
Net Income Avi to Common (ttm)
-5.12M
Diluted EPS (ttm)
-0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
77.17M
Total Debt/Equity (mrq)
64.41%
Levered Free Cash Flow (ttm)
-143.48M
Research Analysis: ACHC
View MoreCompany Insights: ACHC
ACHC does not have Company Insights
Research Reports: ACHC
View MoreLowering target price to $56.00
ACADIA HEALTHCARE CO INC has an Investment Rating of SELL; a target price of $56.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about ACHC?
ACADIA HEALTHCARE CO INC has an Investment Rating of SELL; a target price of $65.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $65.00
ACADIA HEALTHCARE CO INC has an Investment Rating of SELL; a target price of $65.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $65.00
ACADIA HEALTHCARE CO INC has an Investment Rating of SELL; a target price of $65.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice Target